• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

Teva Pharmaceuticals

by FSA Webmaster

Booth #106

41 Moores Road
Frazer, PA 19355
Telephone: 813-244-8679
Website: www.tevapharm-na.com

 

Fentora is a fentanyl citrate buccal tablet for break through cancer pain. Fentora is indicated for the management of breakthrough pain in cancer pain in patients 18 years of age or older and who are already receiving and are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.

Category: 2014 Exhibits, 2015 ExhibitsTag: Teva Pharmaceuticals

About FSA Webmaster

Previous Post:TeamHealth Anesthesia
Next Post:U.S. Anesthesia Partners

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved